|
Prescription Drug Search
Product Request Form
Granisetron is currently not available.
Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Granisetron becomes available, please fill out the form below.
*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!
Browse Alphabetically:
A
·
B
·
C
·
D
·
E
·
F
·
G
·
H
·
I
·
J
·
K
·
L
·
M
·
N
O
·
P
·
Q
·
R
·
S
·
T
·
U
·
V
·
W
·
X
·
Y
·
Z
·
#
Information about CancerDrugsDirect.com
List of countries where we can ship Granisetron:
- Albania
- Algeria
- Anguilla
- Argentina
- Aruba
- Austria
- Bosnia and Herzegovina
- Cayman Islands
- Colombia
- Croatia
- Cuba
- Cyprus
- Czech Republic
- El Salvador
- Estonia
- Finland
- Germany
- Grenada
- Guatemala
- Hong Kong
- India
- Japan
- Lebanon
- Liechtenstein
- Luxembourg
- Mauritius
- Moldova, Republic of
- Monaco
- Poland
- Russian Federation
- Serbia
- Sweden
- Taiwan
- Trinidad and Tobago
- Tunisia
- Turkey
- United Kingdom, UK
- United States, US
- Uruguay
- Vanuatu
Latest news releases on Granisetron:
Apricus Biosciences to Present at the 11th Annual JMP Securities Research Conference - Yahoo Finance
The Company also plans to market in the U.S. or certain other countries the following products: (a) Granisol(R) (granisetron HCI) oral solution, the only FDA-approved, oral, ready-to-use liquid solution of granisetron, (b) Aquoral(TM), an FDA ...
Apricus Biosciences Announces First Quarter 2012 Financial Results Conference Call and Provides Corporate Update - Yahoo Finance
The Company also plans to market in the U.S. or certain other countries the following products: (a) Granisol(R) (granisetron HCI) oral solution, the only FDA-approved, oral, ready-to-use liquid solution of granisetron, (b) Aquoral(TM), an FDA ...
Apricus Biosciences Granted Regulatory Meeting With FDA for Femprox(R) for the Treatment of Female Sexual Arousal Disorder - NASDAQ
The Company also plans to market in the U.S. or certain other countries the following products: (a) Granisol® (granisetron HCI) oral solution, the only FDA-approved, oral, ready-to-use liquid solution of granisetron, (b) Aquoral™, an FDA ...
DGAP-News: Apricus Biosciences Granted Regulatory… - boersennews.de
The Company also plans to market in the U.S. or certain other countries the following products: (a) Granisol(r) (granisetron HCI) oral solution, the only FDA-approved, oral, ready-to-use liquid solution of granisetron, (b) Aquoral(tm), an FDA-cleared ...
Apricus Biosciences Granted Regulatory Guidance With FDA for MycoVa(TM) for the Treatment of Onychomycosis - NASDAQ
The Company also plans to market in the U.S. or certain other countries the following products: (a) Granisol® (granisetron HCI) oral solution, the only FDA-approved, oral, ready-to-use liquid solution of granisetron, (b) Aquoral™, an FDA ...
A.P. Pharma, Inc. : A.P. Pharma Announces First Quarter 2012 Financial Results and Recent Corporate Progress - 4-traders (press release)
The Company completed a thorough QT study for APF530 showing that granisetron, the active drug used in APF530, does not have an effect on cardiac repolarization as measured by prolongation of the QT interval. A separate metabolism study was completed that ...
Tang Capital's Holdings: Insights Into Successful Investing - Seekingalpha.com
A.P. Pharma is developing APF530 (granisetron), a long-acting, subcutaneous drug for the prevention of chemotherapy-induced nausea and vomiting (CINV). APF530 was successfully tested in a large Phase III trial for the treatment of acute- and delayed-onset ...
China Pharma Holdings, Inc. Earnings Conference Call (Q1 2012) - Yahoo! Finance
In addition, it provides Hepatocyte growth-promoting factor to assist and treat viral hepatitis symptoms; Tiopronin for the treatment of acute and chronic Hepatitis B; Omeprazole to treat gastroesophageal reflux disease; Granisetron Hydrochloride ...
